Psoriatic Arthritis
Conference Coverage
Bimekizumab calms psoriatic arthritis in phase 3 ‘BE’ trials
The dual interleukin-17 inhibitor was effective both in patients for whom TNF inhibitors failed and those who had never received a biologic...
Conference Coverage
Biologics, Women, and Pregnancy: What’s Known?
As more studies emerge each year, recommendations will become stronger for considering treatment by certain biological drugs, taking into account...
Conference Coverage
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
Greater percentages of patients treated with one of two doses of the novel IL-17 blocker achieved an ACR50 response versus placebo.
Latest News
Serum brodalumab levels linked with treatment outcomes in patients with psoriasis
Subquantifiable brodalumab levels were associated with a lack of response after 12 weeks in the study.
Feature
Abortion debate may affect Rx decisions for pregnant women
Enactment of abortion restrictions in a growing number of states could have a chilling effect on therapy regimens in pregnant women and their...
Latest News
FDA approves topical tapinarof for plaque psoriasis
Approval was based on results of three studies in a phase 3 clinical trial program, PSOARING, 1, 2, and an open-label extension study, PSOARING 3...
From the Journals
Severe infections often accompany severe psoriasis
Recognizing the risk of rare infections in psoriasis patients promotes early identification and treatment.
Conference Coverage
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
Shielding status was the highest ranked of all the risk factors identified for early mortality from COVID-19.
Conference Coverage
Reduced-frequency methotrexate monitoring causes no harm
Laboratory blood test results were similar despite moving from once every month to about once every 3 months or about once every 5 months during...
News from the FDA/CDC
Upadacitinib earns FDA approval for ankylosing spondylitis
Janus kinase inhibitor offers oral option for patients who have who have had an insufficient response or intolerance with one or more tumor...
From the Journals
Parents’ autoimmune diseases may affect children’s development
Type 1 diabetes and psoriasis in parents, and rheumatoid arthritis in mothers, are associated with increased risk for autism spectrum disorder and...